PWM
ONC

Perigon Wealth Management’s BeOne Medicines Ltd ONC Stock Holding History

Perigon Wealth Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$753K Buy
2,537
+39
+2% +$12.6K 0.01% 623
2025
Q4 		$759K Buy
2,498
+127
+5% +$41.6K 0.01% 629
2025
Q3 		$808K Sell
2,371
-29
-1% -$8.81K 0.02% 581
2025
Q2 		$581K Buy
2,400
+21
+0.9% +$5.15K 0.01% 626
2025
Q1 		$647K Buy
+2,379
New +$556K 0.02% 568

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Perigon Wealth Management's ONC Position: Q1 2026 in Review

Perigon Wealth Management increased its BeOne Medicines Ltd (ONC) stake by 1.6% in Q1 2026, buying an estimated $12.6K and bringing the position to 2,537 shares worth $753K. The position accounts for 0.01% of the portfolio, ranked #623.

Perigon Wealth Management first reported a position in ONC in Q1 2025 and has held it in 5 quarters since. The position peaked at $808K in Q3 2025. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Perigon Wealth Management held 2,537 shares of BeOne Medicines Ltd worth $753K as of Q1 2026.
  • Perigon Wealth Management bought 39 BeOne Medicines Ltd shares in Q1 2026, an estimated $12.6K.
  • BeOne Medicines Ltd made up 0.01% of Perigon Wealth Management's portfolio in Q1 2026, its #623 holding.
  • Perigon Wealth Management first reported a position in BeOne Medicines Ltd in Q1 2025 and has held it in 5 quarters since.
  • Perigon Wealth Management's BeOne Medicines Ltd position peaked at $808K in Q3 2025.
  • 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Perigon Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.